Drug Database
Back to search

United Kingdom· GB-APID-40213411000001101

Tukysa 50mg tablets

A tucatinib product containing tucatinib, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC L01EH03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTukysa 50mg tabletsATCL01EH03REGISTER NO.GB-APID-4021341100000…PACKS LISTED2CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tucatinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tucatinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L01EH03 (tucatinib), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose
Search tucatinib products by name

Tucatinib · ATC L01EH03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tucatinib costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tucatinib · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • FR France$3.96
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tucatinib
Manufacturer
Pfizer Ltd
Country
United Kingdom (GB)
ATC code
L01EH03
ATC class
Tucatinib
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    08720295000135
  • gtin
    5415062122228

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

309 interactions on record for tucatinib.

Graded by severity as the source publishes them — 126 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tucatinib against other medicinesHow interaction checks work

Tucatinib · interactions on record

309 records

  • 126 severe
  • 173 moderate
  • 10 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • BudesonideA07EA06severe
  • EliglustatA16AX10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tucatinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tucatinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Tukysa
  • Liechtenstein · Tukysa
  • Norway · Tukysa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c53c967c-b031-4256-9f7d-b614ae8a992f
GET /v1/drugs/c53c967c-b031-4256-9f7d-b614ae8a992f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "40213411000001101",
  "desc": "Tukysa 50mg tablets (Pfizer Ltd)",
  "form": "Oral tablet",
  "vpid": "40235411000001105",
  "source": "dmd",
  "vtm_id": "871714000",
  "strength": "50 mg",
  "substance": "Tucatinib",
  "ingredient": "Tucatinib",
  "supplier_code": "2082201000001106"
}
API referenceMCP serverPlans

See everything about tucatinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console